Levilimab | Interleukin Related interleukin-related.com

Product Name :
Levilimab

Search keywords :
Levilimab

drugId :
null

Target Vo:
Interleukin-6 receptor alpha subunit

Target Vo Short Name :
IL6RA

Moa_Name:
Interleukin-6 receptor alpha subunit antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Biocad

Active Company_Name :
Biocad

Active Indication_Name:
Coronavirus Disease 2019 (COVID-19)

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ERK2 Antibody
Cleaved-PARP1 Antibody
TNF alpha Antibody: TNF alpha Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 26 kDa, targeting to TNF alpha. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts